Bright Health Group, Inc. (BHG)
NYSE: BHG · IEX Real-Time Price · USD
7.63
+2.37 (45.06%)
At close: Dec 29, 2023, 4:00 PM
7.33
-0.30 (-3.93%)
After-hours: Dec 29, 2023, 7:58 PM EST
Bright Health Group Stock Forecast
Stock Price Forecast
According to 5 stock analysts, the average 12-month stock price forecast for BHG stock stock is $26, which predicts an increase of 240.76%. The lowest target is $8.00 and the highest is $85. On average, analysts rate BHG stock stock as a hold.
Analyst Consensus: Hold
* Price targets were last updated on Aug 30, 2023.
Analyst Ratings
The average analyst rating for BHG stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 3 | 2 |
| Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell Maintains $160 → $8 | Sell | Maintains | $160 → $8 | +4.85% | Aug 30, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $13 → $16 | Hold | Maintains | $13 → $16 | +109.70% | Aug 14, 2023 |
| Nephron Research | Nephron Research | Hold → Strong Buy Upgrades $85 | Hold → Strong Buy | Upgrades | $85 | +1,014.02% | Jun 30, 2023 |
| Barclays | Barclays | Buy → Sell Downgrades $4 → $8 | Buy → Sell | Downgrades | $4 → $8 | +4.85% | Jun 15, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $80 → $13 | Hold | Maintains | $80 → $13 | +70.38% | May 30, 2023 |
Financial Forecast
Revenue This Year
1.17B
from 2.41B
Decreased by -51.66%
Revenue Next Year
1.30B
from 1.17B
Increased by 11.06%
EPS This Year
-95.36
from -190.40
EPS Next Year
-11.81
from -95.36
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 1.2B | 1.4B | 1.6B |
| Avg | 1.2B | 1.3B | 1.6B |
| Low | 1.1B | 1.2B | 1.5B |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -49.4% | 23.0% | 26.1% |
| Avg | -51.7% | 11.1% | 21.3% |
| Low | -53.4% | 0.7% | 17.7% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -99.14 | -12.27 | -11.71 |
| Avg | -95.36 | -11.81 | -11.26 |
| Low | -92.53 | -11.46 | -10.93 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.